Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy: Cell Death and Disease

B. Montico, F. Colizzi, G. Giurato, A. Rizzo, A. Salvati, L. Baboci, D. Benedetti, E. Pivetta, A. Covre, Michele Dal Bo, A. Weisz, A. Steffan, M. Maio, L. Sigalotti, E. Fratta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy: Cell Death and Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences